Studies have demonstrated that high concentrations of circulating glucose and LDL/VLDL lipoproteins stimulate myocardial NF-κB activation in diabetic cardiomyopathy [41], [42]. This evidence concerns the gene NFKB1 and diabetic cardiomyopathy.